China · Delayed Price · Currency is CNY APT Medical Statistics
Total Valuation
APT Medical has a market cap or net worth of CNY 29.62 billion. The enterprise value is 28.38 billion.
| Market Cap | 29.62B |
| Enterprise Value | 28.38B |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | May 14, 2026 |
Share Statistics
APT Medical has 140.64 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 140.64M |
| Shares Outstanding | 140.64M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | -0.83% |
| Owned by Insiders (%) | 20.04% |
| Owned by Institutions (%) | 33.50% |
| Float | 75.03M |
Valuation Ratios
The trailing PE ratio is 34.36 and the forward PE ratio is 27.07.
| PE Ratio | 34.36 |
| Forward PE | 27.07 |
| PS Ratio | 10.87 |
| PB Ratio | 9.85 |
| P/TBV Ratio | 11.69 |
| P/FCF Ratio | 42.17 |
| P/OCF Ratio | 29.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.77, with an EV/FCF ratio of 40.41.
| EV / Earnings | 32.73 |
| EV / Sales | 10.42 |
| EV / EBITDA | 26.77 |
| EV / EBIT | 30.05 |
| EV / FCF | 40.41 |
Financial Position
The company has a current ratio of 5.20, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.20 |
| Quick Ratio | 3.74 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | 1,158.81 |
Financial Efficiency
Return on equity (ROE) is 29.72% and return on invested capital (ROIC) is 48.48%.
| Return on Equity (ROE) | 29.72% |
| Return on Assets (ROA) | 17.96% |
| Return on Invested Capital (ROIC) | 48.48% |
| Return on Capital Employed (ROCE) | 30.78% |
| Weighted Average Cost of Capital (WACC) | 2.33% |
| Revenue Per Employee | 873,550 |
| Profits Per Employee | 278,038 |
| Employee Count | 3,118 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 1.67 |
Taxes
In the past 12 months, APT Medical has paid 134.63 million in taxes.
| Income Tax | 134.63M |
| Effective Tax Rate | 13.63% |
Stock Price Statistics
The stock price has decreased by -25.34% in the last 52 weeks. The beta is -0.35, so APT Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.35 |
| 52-Week Price Change | -25.34% |
| 50-Day Moving Average | 240.43 |
| 200-Day Moving Average | 262.09 |
| Relative Strength Index (RSI) | 28.50 |
| Average Volume (20 Days) | 1,377,873 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APT Medical had revenue of CNY 2.72 billion and earned 866.92 million in profits. Earnings per share was 6.13.
| Revenue | 2.72B |
| Gross Profit | 1.97B |
| Operating Income | 944.49M |
| Pretax Income | 988.00M |
| Net Income | 866.92M |
| EBITDA | 1.05B |
| EBIT | 944.49M |
| Earnings Per Share (EPS) | 6.13 |
Balance Sheet
The company has 1.29 billion in cash and 14.55 million in debt, with a net cash position of 1.28 billion or 9.08 per share.
| Cash & Cash Equivalents | 1.29B |
| Total Debt | 14.55M |
| Net Cash | 1.28B |
| Net Cash Per Share | 9.08 |
| Equity (Book Value) | 3.01B |
| Book Value Per Share | 21.22 |
| Working Capital | 1.52B |
Cash Flow
In the last 12 months, operating cash flow was 993.29 million and capital expenditures -291.00 million, giving a free cash flow of 702.29 million.
| Operating Cash Flow | 993.29M |
| Capital Expenditures | -291.00M |
| Depreciation & Amortization | 106.25M |
| Net Borrowing | 3.98M |
| Free Cash Flow | 702.29M |
| FCF Per Share | 4.99 |
Margins
Gross margin is 72.48%, with operating and profit margins of 34.68% and 31.83%.
| Gross Margin | 72.48% |
| Operating Margin | 34.68% |
| Pretax Margin | 36.27% |
| Profit Margin | 31.83% |
| EBITDA Margin | 38.58% |
| EBIT Margin | 34.68% |
| FCF Margin | 25.78% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | -42.86% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 19.64% |
| Buyback Yield | -0.07% |
| Shareholder Yield | 0.38% |
| Earnings Yield | 2.93% |
| FCF Yield | 2.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 19, 2025. It was a forward split with a ratio of 1.45.
| Last Split Date | Jun 19, 2025 |
| Split Type | Forward |
| Split Ratio | 1.45 |
Scores
APT Medical has an Altman Z-Score of 57.94 and a Piotroski F-Score of 7.
| Altman Z-Score | 57.94 |
| Piotroski F-Score | 7 |